News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
159 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25277)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3635)
June (2415)
July (2091)
August (2652)
September (2458)
October (477)
Day
2 (202)
3 (126)
4 (116)
5 (123)
6 (51)
9 (127)
10 (95)
11 (131)
12 (128)
13 (61)
16 (159)
17 (116)
18 (142)
19 (71)
20 (36)
23 (191)
24 (140)
25 (137)
26 (112)
27 (81)
30 (70)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
Duchenne muscular dystrophy
UPDATE: Second Patient Dies After Receiving Sarepta’s DMD Gene Therapy Elevidys
Sarepta’s shares crashed 41% in premarket trading Monday morning to $21.01 after the biotech reported a second death from acute liver failure, a known side effect of adeno-associated virus-based gene therapies.
June 16, 2025
·
3 min read
·
Tristan Manalac
Weight loss
Lilly Notches ‘Top-Tier’ Weight Loss Results for Phase I Amylin/Tirzepatide Combo
At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were also impressed by the tolerability profile.
June 16, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
June 16, 2025
·
7 min read
Press Releases
Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress
June 16, 2025
·
9 min read
Press Releases
Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
June 16, 2025
·
3 min read
Press Releases
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
3 min read
Press Releases
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
June 16, 2025
·
17 min read
Press Releases
Grace Therapeutics to Participate in the 2025 BIO International Conference
June 16, 2025
·
3 min read
Press Releases
Aptevo Participating in the BIO International Convention
June 16, 2025
·
5 min read
Press Releases
Johnson & Johnson’s dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma
June 16, 2025
·
9 min read
Previous
2 of 16
Next
